Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Debt to Equity: 2020-2024

Historic Debt to Equity for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $1.24.

  • Journey Medical's Debt to Equity fell 46.35% to $0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.48, marking a year-over-year increase of 92.39%. This contributed to the annual value of $1.24 for FY2024, which is 72.53% up from last year.
  • Latest data reveals that Journey Medical reported Debt to Equity of $1.24 as of FY2024, which was up 72.53% from $0.72 recorded in FY2023.
  • Journey Medical's Debt to Equity's 5-year high stood at $1.34 during FY2022, with a 5-year trough of $0.02 in FY2021.
  • In the last 3 years, Journey Medical's Debt to Equity had a median value of $1.24 in 2024 and averaged $1.10.
  • Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 96.19% in 2021, then surged by 6,843.66% in 2022.
  • Yearly analysis of 5 years shows Journey Medical's Debt to Equity stood at $0.51 in 2020, then plummeted by 96.19% to $0.02 in 2021, then surged by 6,843.66% to $1.34 in 2022, then crashed by 46.42% to $0.72 in 2023, then spiked by 72.53% to $1.24 in 2024.